Invivodata Captures Symptom Relief Data In Endometriosis Trial
Oct 1st 2008Drug InformationEndocrinology
Your best medicine news resource
Oct 1st 2008Drug InformationEndocrinology
Oct 1st 2008Drug InformationEndocrinology
Bionovo, Inc. (Nasdaq: BNVI) will present an abstract in a presentation on their new drug candidate, VG101, for the treatment of vaginal dryness, at the 19th Annual Meeting of the North American Menopause Society in Orlando, Florida on September 26, 2008. Dr. Mary Tagliaferri, president and chief medical officer of Bionovo, will provide seminal information on the company’s second estrogen receptor beta selective drug candidate that will be entering clinical trials shortly.
More: continued here
Sep 30th 2008Drug InformationEndocrinology
Hepatic encephalopathy, a major complication of cirrhosis, is a clinical syndrome characterized by mental status changes in patients with severe hepatic insufficiency. Hormonal disorders and circadian rhythm abnormalities are often associated with liver disease, and the severity of these disorders is related to liver disease severity and duration. The role of melatonin is critical, as diurnal melatonin rhythm disruption may significantly contribute to circadian function alterations.
More: continued here
Sep 30th 2008Drug InformationEndocrinology
The use of hormone therapy was associated with a reduced risk of breast cancer in postmenopausal women who carry BRCA mutations, according to a case-control study published online September 23 in the Journal of the National Cancer Institute. Women who carry a mutation in the BRCA1 gene may opt to have their ovaries removed to lower their risk of developing breast cancer.
More: continued here
Sep 30th 2008Drug InformationEndocrinology
Anabolic steroids are synthetic hormones derived from the human male hormone testosterone. The use of steroids has been suspected in professional baseball and other sports where building muscle strength, rather than endurance, is paramount. Power lifting is such a sport. A team of researchers has examined the impact of anabolic steroid use on power lifters years after the athletes had ceased to take the drugs.
More: continued here
Sep 30th 2008Drug InformationEndocrinology
Why is your mate’s rendition of Marvin Gaye’s “Let’s Get it On” cute and sexy sometimes and so annoying at other times? A songbird study conducted by Emory University sheds new light on this question, showing that a change in hormone levels may alter the way we perceive social cues by altering a system of brain nuclei, common to all vertebrates, called the “social behavior network.
More: continued here
Sep 30th 2008Drug InformationEndocrinology
For men with locally advanced prostate cancer the addition of radiation treatment to anti-androgen hormone therapy reduces the risk of dying of prostate cancer by 50 percent compared to those who have anti-androgen hormone treatment alone, according to a randomized study presented at the American Society for Therapeutic Radiology and Oncology’s 50th Annual Meeting in Boston.
More: continued here
Sep 30th 2008Drug InformationEndocrinology
Men over 70 years of age with early-stage prostate cancer have 20 percent higher mortality if they are treated first with hormone therapy before being treated with radiation seed implants (brachytherapy), compared to men who are treated with brachytherapy alone, according to the largest cohort study of its kind presented September 23, 2008, at the American Society for Therapeutic Radiology and Oncology’s 50th Annual Meeting in Boston.
More: continued here
Sep 30th 2008Drug InformationEndocrinology
Olympus has announced the introduction of its new Enzymatic Creatinine assay, suitable for use across the range of Olympus diagnostic analysers. It is intended for use for quantitative determination of creatinine in human serum, plasma and urine. The new assay utilises an enzymatic method to achieve greater accuracy, showing less interference to bilirubin and antibiotics.
More: continued here
Sep 30th 2008Drug InformationEndocrinology
Using one of the largest databases of prostate cancer outcomes in the United States, Fox Chase Cancer Center researchers have developed a prediction tool that uses a patient’s clinical information to estimate the benefit of adding androgen deprivation therapy of various durations to radiation therapy.
More: continued here